The DEA has just passed approval for Syndros, a synthetic form of cannabis made by the pharmaceutical company, Insys Therapeutics.
Syndros will be used to help treat vomiting and nausea that are associated with chemotherapy.
Last summer the FDA approved it for AIDS and cancer patients, despite keeping marijuana in Schedule II of the Controlled Substance Act, most notably for high addictive and “high potential for abuse” drugs.
Schedule II drugs are morphine, cocaine, vicodin, Percocet and other prescription painkillers.
Insys Therapeutics contributed $500,000 in defeating Arizona’s marijuana legalization campaign. Meanwhile it receives the approval from the DEA for its synthetic cannabis drug. Insys stated that the legalization bill failed to ensure protection of children and other citizens in Arizona.
Because of their obstructive efforts, those who smoke cannabis recreationally will still face felony charges for small amounts of marijuana in their possession. Even though they view safety as a top priority, they are fiercely marketing their fentanyl (Powerful, addictive opiate that is 100x stronger than morphine) containing drug, Subsys, says different.
The pharmaceutical company is working on eliminating the non-pharmaceutical market for marijuana to ensure they are profiting off it.
They are not looking out for the best interests for consumers. A lot of Americans are dying from prescription painkiller overdoes annually, yet marijuana has yet to have killed someone.
- Source diyhealth.tips